Question for an investor with more biopharma experience:
What is the average kind of lag time or interval between phase trials?
Say sepsis final readout and tick of approval comes in June. How long before they get the ball rolling on phase 2. Do they have some interim work to do, or generally apply for approval straight away?
TIA
RCE Charts, page-1964
-
- There are more pages in this discussion • 209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.3M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 55.5¢ | 54.0¢ | $17.46K | 31.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13261 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 10024 | 4 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |